Pfizer Scales Back Covid Vaccine Production Targets

The transcript discusses Pfizer's vaccine rollout, focusing on the unchanged dose numbers and challenges in production due to the novelty of mRNA technology. It highlights the regulatory speed and distribution plans in the UK and US, with initial doses expected by mid-December. The discussion emphasizes the unprecedented scale of vaccine production and the potential for minor supply chain hiccups.

What is the expected timeline for the vaccine to be administered in the UK?

When is the advisory panel in the United States scheduled to review the vaccine?